Cardiovascular injury due to SARS-CoV-2
CL Bugert, V Kwiat, IC Valera, JJ Bugert… - Current clinical …, 2021 - Springer
CL Bugert, V Kwiat, IC Valera, JJ Bugert, MS Parvatiyar
Current clinical microbiology reports, 2021•SpringerAbstract Purpose of Review The world is currently facing the largest global health crisis
since the early 1900s due to a novel coronavirus. While SARS-CoV-2 infection causes
predictable symptoms in COVID-19 patients, including upper respiratory distress and fever,
the heterogeneity of manifestations is surprising. This review focuses on direct and indirect
causes of myocardial injury in COVID-19 patients and highlights current knowledge,
treatment strategies, and outstanding questions in the field. Recent Findings Data are …
since the early 1900s due to a novel coronavirus. While SARS-CoV-2 infection causes
predictable symptoms in COVID-19 patients, including upper respiratory distress and fever,
the heterogeneity of manifestations is surprising. This review focuses on direct and indirect
causes of myocardial injury in COVID-19 patients and highlights current knowledge,
treatment strategies, and outstanding questions in the field. Recent Findings Data are …
Purpose of Review
The world is currently facing the largest global health crisis since the early 1900s due to a novel coronavirus. While SARS-CoV-2 infection causes predictable symptoms in COVID-19 patients, including upper respiratory distress and fever, the heterogeneity of manifestations is surprising. This review focuses on direct and indirect causes of myocardial injury in COVID-19 patients and highlights current knowledge, treatment strategies, and outstanding questions in the field.
Recent Findings
Data are emerging that highlight the extent of cardiovascular involvement in COVID-19 patients, including evidence that SARS-CoV-2 causes myocarditis and increases cardiac risk. The incidence of cardiac injury is much greater in patients with severe disease presentation and those in intensive care.
Summary
During the past year, COVID-19 patient mortality rates have improved due to tailored pharmacological treatments and patient management strategies that address the unique presentation of symptoms, which will hopefully also reduce the incidence of cardiac injury.
Springer